Article Details

Patient with Becker muscular dystrophy dosed in pilot trial - Labiotech.eu

Retrieved on: 2022-08-22 09:18:42

Tags for this article:

Click the tags to see associated articles and topics

Patient with Becker muscular dystrophy dosed in pilot trial - Labiotech.eu. View article details on HISWAI: https://www.labiotech.eu/trends-news/first-patient-dosed-phase-2-pilot-study-treatment-muscular-dystrophy/

Excerpt

Eric Hoffman, CEO of ReveraGen BioPharma, said: “There are currently no approved drugs for BMD in any country, and no drugs in clinical development ...

Article found on: www.labiotech.eu

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up